Literature DB >> 29908419

Characterization of chronic myelomonocytic leukemia with TP53 mutations.

Wei Wang1, Mark J Routbort2, Sanam Loghavi2, Zhenya Tang2, L Jeffrey Medeiros2, Sa A Wang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29908419     DOI： 10.1016/j.leukres.2018.05.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  4 in total

Review 1.  Recent Updates on Chronic Myelomonocytic Leukemia.

Authors:  Sanam Loghavi; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

2.  TP53 and the star-crossed lovers MDS and AML.

Authors:  John S Welch
Journal:  Blood       Date:  2022-04-14       Impact factor: 25.476

3.  Mutational landscape of chronic myelomonocytic leukemia in Chinese patients.

Authors:  Yanbo Nie; Liang Shao; Hong Zhang; Colin K He; Hongyu Li; Junyan Zou; Long Chen; Huaiyue Ji; Hao Tan; Yani Lin; Kun Ru
Journal:  Exp Hematol Oncol       Date:  2022-05-24

Review 4.  Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.

Authors:  Alexandra Higgins; Mithun Vinod Shah
Journal:  Genes (Basel)       Date:  2020-07-06       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.